GENERA

You are currently browsing the Biofortified GENetic Engineering Risk Atlas (GENERA). This is a database of published, peer-reviewed scientific papers that are related to the risks and safety of genetic engineering in agriculture. You can search the Atlas below.

There are currently 6 studies in the Atlas.
Click here to return to browsing.

About this study

Publication Status:
peer reviewed

Crops Studied:
maize

Type of Study:
nutritional
review
other
feeding study

Source of Funding:
There is currently no entry for this detail.
Country
United States of America

Study Findings:
Positive

Search the Atlas

Help build the Atlas

Would you like to submit a study that is not included in the Atlas? Please contact our Editors here.
We are also looking for volunteers who would like to help enter studies into the Atlas.

About Biofortified

Biofortified's volunteer authors are devoted to providing factual information and fostering discussion about plant genetics, especially genetic engineering. The site is written by grad students, professors, and guest experts. Meet our authors on the Authors page.

Further evaluation of disputed animal tests carried out on corn MON 863

Share

Citation:

Doull JGaylor DGreim HALovell DPLynch BMunro IC. (2007) Report of an Expert Panel on the reanalysis by of a 90-day study conducted by Monsanto in support of the safety of a genetically modified corn variety (MON 863). Food Chem Toxicol. 2007 Nov;45(11):2073-85. Epub 2007 Aug 30.

Content Summary

An earlier report by Séralini and others 2007  had reanalysed an even earlier report describing animal feeding studies carried out on corn variety MON 863. Doull and others 2007 examine the statistical and toxicological arguments of Séralini and others 2007 and conclude that they provide no convincing evidence for any harmful health effect of  corn MON 863.

Abstract

MON 863, a genetically engineered corn variety that contains the gene for modified Bacillus thuringiensis Cry3Bb1 protein to protect against corn rootworm, was tested in a 90-day toxicity study as part of the process to gain regulatory approval. This study was reanalyzed by Séralini et al. who contended that the study showed possible hepatorenal effects of MON 863. An Expert Panel was convened to assess the original study results as analyzed by the Monsanto Company and the reanalysis conducted by Séralini et al. The Expert Panel concludes that the Séralini et al. reanalysis provided no evidence to indicate that MON 863 was associated with adverse effects in the 90-day rat study. In each case, statistical findings reported by both Monsanto and Séralini et al. were considered to be unrelated to treatment or of no biological or clinical importance because they failed to demonstrate a dose-response relationship, reproducibility over time, association with other relevant changes (e.g., histopathology), occurrence in both sexes, difference outside the normal range of variation, or biological plausibility with respect to cause-and-effect. The Séralini et al. reanalysis does not advance any new scientific data to indicate that MON 863 caused adverse effects in the 90-day rat study

Leave a Reply

 

 

 

You can use these HTML tags

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>